ClinicalTrials.Veeva

Menu

Night Owl Metabolism

Johns Hopkins University logo

Johns Hopkins University

Status

Enrolling

Conditions

Impaired Glucose Tolerance
Overweight
PreDiabetes

Treatments

Behavioral: Timing of Standardized Meal
Diagnostic Test: Timing of OGTT

Study type

Interventional

Funder types

Other
Industry
NIH

Identifiers

NCT06507722
IRB00428863

Details and patient eligibility

About

The proposed study uses a novel and rigorous randomized cross-over study design in youth (17-23y) with late and non-late chronotype (n=35 per group) to assess the glycemic effect of "aligning" an oral glucose tolerance test (OGTT) or first-meal of day to a subject's chronotype. Both groups will undergo 2 OGTTs (aligned and mis-aligned with chronotype) to compare glucose tolerance and insulin sensitivity within-subject (primary outcome) and between groups (Aim 1). Then, youth will also undergo two standardized meals (aligned and mis-aligned with chronotype) while wearing continuous glucose monitoring to compare post-prandial glucose excursions within-subject and between groups (Aim 2). A pilot Exploratory Aim 3 (n=12 per group) will investigate delayed melatonin patterns under dim-light as a potential pathophysiologic mechanism behind abnormal glucose tolerance in youth with late chronotype on morning OGTTs.

Enrollment

70 estimated patients

Sex

All

Ages

18 to 23 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Overweight similar to (BMI ≥ 85th percentile but <95th percentile for age and sex per Centers for Disease Control and Prevention growth curves (as Centers for Disease Control and Prevention growth curves contain ages ≤ 20y; if ages 21-23 years, the BMI ≥ 85th and <95th percentile equivalents for a 20-year-old will be used))
  • Post-pubertal
  • Normal sleep duration (avg. >7 hours of sleep per night)
  • Social jetlag (difference between weekend and weekday sleep) of < 2 hours.

Exclusion criteria

  • Known diabetes, sleep disorders, major organ system illness, pregnancy, or genetic syndrome
  • Medication use known to affect insulin sensitivity, glucose tolerance, or circadian rhythm
  • Screening high risk for obstructive sleep apnea
  • Night shift work.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Double Blind

70 participants in 2 patient groups

Cohort A - Late Chronotype first, then alternate
Other group
Description:
Sleep onset after 2am
Treatment:
Diagnostic Test: Timing of OGTT
Behavioral: Timing of Standardized Meal
Cohort B - Non-late Chronotype first, then alternate
Other group
Description:
Sleep onset before 11pm
Treatment:
Diagnostic Test: Timing of OGTT
Behavioral: Timing of Standardized Meal

Trial documents
1

Trial contacts and locations

1

Loading...

Central trial contact

Talia Hitt, MD/MPH/MSHP

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems